DB16270Investigational
Ontuxizumab is a humanized monoclonal antibody that targets endosialin or tumour endothelial marker 1 (TEM-1). It is under investigation in clinical trial NCT01574716 (Sarcoma Study of Morab-004 Utilization: Research and...
- Mechanism
- Curator reviewed
Pharmacologically active on Endosialin
- Also known as
- Ontecizumab
- Code names
- MORAb-004
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Ontuxizumab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account